Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1458 to 1507 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
katanin p60 subunit a 1. [source:refseq;acc:nm\_007044]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2574\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4327.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4248.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01863\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
katanin p80 subunit b 1; katanin (80 kda); katanin p80 (wd40-containing) subunit b 1. [source:refseq;acc:nm\_005886]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2580\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4331.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4252.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01848\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kccr13l. [source:refseq;acc:nm\_139179]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1159\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5538.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6025.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08787\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kelch-like ech-associated protein 1 (cytosolic inhibitor of nrf2). [source:swissprot;acc:q14145]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1494\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4619.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4965.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07482\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kelch-like protein 8. [source:swissprot;acc:q9p2g9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1670\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5791.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6193.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0694\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
keratin associated protein 1-3; keratin associated protein 1.3. [source:refseq;acc:nm\_030966]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1875\vspace{3pt}}&\multirow{10}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.14\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
keratin associated protein 1.5. [source:refseq;acc:nm\_031957]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1861\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
keratin associated protein 2-4; keratin associated protein 2.4. [source:refseq;acc:nm\_033184]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1857\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.15\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
keratin associated protein 4-10; keratin associated protein 4.10. [source:refseq;acc:nm\_033060]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1854\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.14\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
keratin associated protein 4-12; keratin associated protein 4.12. [source:refseq;acc:nm\_031854]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1860\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.13\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
keratin associated protein 4-14; keratin associated protein 4.14. [source:refseq;acc:nm\_033059]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1858\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
keratin associated protein 4-2; keratin associated protein 4.2. [source:refseq;acc:nm\_033062]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1855\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.14\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
keratin associated protein 4.3 (fragment). [source:sptrembl;acc:q9byr4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1856\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
keratin associated protein 4.4. [source:refseq;acc:nm\_032524]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1866\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
keratin associated protein 4.9 (fragment). [source:sptrembl;acc:q9byq8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1859\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.13\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
keratin associated protein 9-4; keratin associated protein 9.4. [source:refseq;acc:nm\_033191]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1881\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6076.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6462.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0635\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
keratin associated protein 9.2. [source:refseq;acc:nm\_031961]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1853\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6076.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6463.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06368\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
keratin, ultra high-sulfur matrix protein a (uhs keratin a) (uhs kera). [source:swissprot;acc:p26371]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1864\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
keratin, ultra high-sulfur matrix protein b (uhs keratin b) (uhs kerb). [source:swissprot;acc:o75690]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1863\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ketohexokinase (ec 2.7.1.3) (hepatic fructokinase). [source:swissprot;acc:p50053]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1443\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5450.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5869.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07672\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kh domain containing, rna binding, signal transduction associated 1; gap-associated tyrosine phosphoprotein p62 (sam68). [source:refseq;acc:nm\_006559]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
58\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1631.67\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
2664.55\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.63302\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
kh domain containing, rna binding, signal transduction associated 3; sam68-like phosphotyrosine protein, t-star. [source:refseq;acc:nm\_006558]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
57\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
kh domain-containing, rna-binding, signal transduction-associated protein 2; sam68-like mammalian protein 1. [source:refseq;acc:nm\_152688]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
59\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kh-type splicing regulatory protein (fuse binding protein 2); kh-type splicing regulatory protein (fuse-binding protein 2). [source:refseq;acc:nm\_003685]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2090\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5817.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6138.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05527\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kiaa1194. [source:refseq;acc:nm\_015455]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3061\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kidney and liver proline oxidase 1. [source:refseq;acc:nm\_021232]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1165\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6604.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7183.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08761\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kinesin family member c3. [source:refseq;acc:nm\_005550]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
909\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5995.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6595.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10005\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kinesin heavy chain (ubiquitous kinesin heavy chain) (ukhc). [source:swissprot;acc:p33176]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2043\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6036.68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6379.44\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05678\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
kinesin heavy chain isoform 5c (kinesin heavy chain neuron-specific 2). [source:swissprot;acc:o60282]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2044\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
kinesin light chain 1 (klc 1). [source:swissprot;acc:q07866]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2046\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6036.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6379.48\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
kinesin light chain 2 (klc 2). [source:swissprot;acc:q9h0b6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2042\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6036.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6379.38\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kinesin protein. [source:refseq;acc:nm\_032559]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1096\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5356.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5842.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09072\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kinesin-like protein kif13a (kinesin-like protein rbkin). [source:swissprot;acc:q9h1h9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2215\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5910.12\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6199.28\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04893\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
kinesin-like protein kif13b (kinesin-like protein gakin). [source:swissprot;acc:q9nqt8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2217\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kinesin-like protein kif2 (kinesin-2) (hk2). [source:swissprot;acc:o00139]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1104\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5359.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5844.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09054\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kinesin-like protein kif23 (mitotic kinesin-like protein-1) (kinesin- like protein 5). [source:swissprot;acc:q02241]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1790\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5839.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6227.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06637\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kinesin-like protein kif3b (microtubule plus end-directed kinesin motor 3b) (hh0048). [source:swissprot;acc:o15066]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2014\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5934.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6281.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0585\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kinesin-like protein kif3c. [source:swissprot;acc:o14782]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2021\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5934.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6281.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05844\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kininogen precursor (alpha-2-thiol proteinase inhibitor) [contains: bradykinin]. [source:swissprot;acc:p01042]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
631\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6228.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7013.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.126\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
krueppel-like factor 5 (intestinal-enriched krueppel-like factor) (colon krueppel-like factor) (transcription factor bteb2) (basic transcription element binding protein 2) (bte-binding protein 2) (gc box binding protein 2). [source:swissprot;acc:q13887]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
297\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4911.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5909.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20306\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kruppel-related zinc finger protein hckrox. [source:refseq;acc:nm\_015872]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2571\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7056.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7194.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01963\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kv channel interacting protein 1; vesicle apc-binding protein; a-type potassium channel modulatory protein 1. [source:refseq;acc:nm\_014592]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
138\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2755.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2094.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.31555\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kv channel interacting protein 2 isoform 4; a-type potassium channel modulatory protein 2; cardiac voltage gated potassium channel modulatory subunit. [source:refseq;acc:nm\_173193]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
140\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2760.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2100.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.31425\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kynureninase (ec 3.7.1.3) (l-kynurenine hydrolase). [source:swissprot;acc:q16719]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
610\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8430.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9518.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12907\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase). [source:refseq;acc:nm\_003679]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2165\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6952.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7315.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05212\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
l-myc-1 proto-oncogene protein. [source:swissprot;acc:p12524]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
450\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4889.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5610.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14753\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
lactamase, beta 2. [source:refseq;acc:nm\_016027]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2914\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
lactoylglutathione lyase (ec 4.4.1.5) (methylglyoxalase) (aldoketomutase) (glyoxalase i) (glx i) (ketone-aldehyde mutase) (s-d-lactoylglutathione methylglyoxal lyase). [source:swissprot;acc:q04760]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2016\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6555.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6938.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05849\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
lag1 longevity assurance homolog 2 isoform 1; l3 pigment; tumor metastasis-suppressor. [source:refseq;acc:nm\_022075]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
96\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4110.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5694.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.3856\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
lamin a/c (70 kda lamin). [source:swissprot;acc:p02545]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2119\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5976.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6301.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05434\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/